Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable

Cell-in-cell (CIC) structures in breast cancer have so far been studied in a small inhomogeneous patient population, suggesting the prognostic importance of CIC. In the present study, we focused on CIC in early hormone-sensitive breast cancer. With in vitro co-culture experiments, we compared the homotypic phagocytic capacity of two breast cancer cell lines to that of primary human fibroblasts. Afterward, we studied 601 tissue specimens from 147 patients participating in an institutional accelerated partial breast irradiation (APBI) phase II trial. Both breast cancer cell lines performed non-professional phagocytosis at a higher rate than primary human fibroblasts. In this study cohort, 93.2% of the patients had T1 tumours, and 6.8% had T2 tumours. CIC was found in 61.2% of the patients, with a CIC rate ranging from <1/mm(2) to 556.5/mm(2) with a mean of 30.9/mm(2) +/- 68.4/mm(2). CIC structures were prognostically favourable for local recurrence-free survival and disease-free survival. Regarding metastasis-free survival, CIC-positive patients had an unfavourable prognosis. Subgroup analysis indicated a correlation between a high proliferation index and high CIC rates. CIC had the highest prognostic value in young breast cancer patients (p = 0.004). With this study, we provide further evidence of CIC as a prognostic marker in breast cancer.

Automated summary

Cell-in-cell (CIC) structures in early hormone-sensitive breast cancer were studied. In vitro experiments showed that breast cancer cell lines had higher phagocytic capacity compared to primary human fibroblasts. Tissue analysis from 147 patients in a clinical trial revealed that CIC structures were associated with favorable local recurrence-free survival and disease-free survival, but unfavorable for metastasis-free survival. CIC had the highest prognostic value in young breast cancer patients.